Tracking Colistin-Treated Patients to Monitor the Incidence and Outcome of Carbapenem-Resistant Gram-Negative Infections | Zendy

Sameer S. Kadri | Zendy; Samuel F. Hohmann | Zendy; E. John Orav | Zendy; Stephanie Bonne | Zendy; Matthew A Moffa | Zendy; Joseph Timpone | Zendy; Jeffrey R. Strich | Zendy; Tara N. Palmore | Zendy; Kenneth B. Christopher | Zendy; Christy Varughese | Zendy; David C. Hooper | Zendy; Robert L. Danner | Zendy

Open Access

Tracking Colistin-Treated Patients to Monitor the Incidence and Outcome of Carbapenem-Resistant Gram-Negative Infections

Author(s) -

Sameer S. Kadri,

Samuel F. Hohmann,

E. John Orav,

Stephanie Bonne,

Matthew A Moffa,

Joseph Timpone,

Jeffrey R. Strich,

Tara N. Palmore,

Kenneth B. Christopher,

Christy Varughese,

David C. Hooper,

Robert L. Danner

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu741

Subject(s) - colistin , medicine , carbapenem , incidence (geometry) , intensive care unit , odds ratio , retrospective cohort study , mortality rate , cohort , pediatrics , emergency medicine , intensive care medicine , antibiotics , microbiology and biotechnology , physics , optics , biology

Existing surveillance mechanisms may underestimate the incidence of carbapenem-resistant gram-negative infections (CRGNIs). Although carbapenem resistance increases the risk of death, the trend in mortality over time is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research